Report me for selling fake medicine? Why are you crying when your illness relapses?

So, she wanted to get involved.

If Pfizer is targeted, it will also be beneficial to Novartis.

Pfizer is also one of Novartis's competitors, but the competition has not reached the level of life and death.

To be precise, every pharmaceutical company is a competitor to other pharmaceutical companies outside.

Now that Pfizer is in a mess, she naturally doesn't mind taking advantage of the situation.

This way I can also do Chen Xuan a favor.

"Chen Xuan's new drug is also undergoing clinical trials."

"The scale of his clinical trials is still very large, and this is the most expensive stage."

"I don't know if he's short on cash. He's shown in the past that he definitely won't sell the formula, so will he accept financing?"

After thinking of the countermeasures, Anna thought about the recipe again.

There is no way. Chen Xuan’s several formulas have very high market value, even far inferior to the special medicine for liver cancer.

In this situation, how could she give up easily?

If there was no chance at all, then she would have to give up, but now it seems there is still a chance for cooperation.

This made her want to invest in his new drug trial, whether in her personal capacity or in the name of Novartis, and she hoped to cooperate with him.

Now is the stage when he is burning the most money, and it is also very likely the time when he needs money the most.

Since we can't buy the formula, cooperation through financing seems to be a good option.

"First keep an eye on Pfizer and see what they do next."

"If I can get important information, I can even do Chen Xuan a favor."

"By then, if I want to cooperate with him, the chances will be much greater. This favor is very important."

Anna had already made up her mind.

Although she had not spent much time with Chen Xuan, she knew this man's character very well.

Those who are grateful and kind to him will be rewarded tenfold or a hundredfold. If you can make him owe you a favor, it is basically a sure win.

Therefore, what she wanted most now was to do him a favor.

However, this favor is not so easy to find, and she can't sell it just because she wants to.

Favors are not something you can sell just because you want to.

Similarly, Anna wanted to raise funds to invest in Cheng Xuan's new drug project, but this opportunity would not appear just because she thought it would, and Chen Xuan might not be short of money.

Anna knew this, of course, and was just taking the opportunity to give it a try.

……

Pfizer Headquarters,

In the chairman's office.

"A specific drug for pancreatic cancer and a specific drug for HIV?"

"How on earth did he do it? Is our entire lab no match for him alone?"

"Also, was the reason he developed these drugs intentionally targeting Pfizer, or was it just a coincidence?"

Pfizer's chairman and CEO Murthy said with a very grim expression.

This was a middle-aged man who looked burly and strong. He had a very powerful aura. Ordinary people didn't dare to look him in the eye. There was an inexplicable sense of oppression all over his body.

But at this time he looked a little embarrassed.

……

……

no way,

Murthy doesn’t know whether other pharmaceutical giants have been affected.

But the impact on Pfizer is too great.

Although Pfizer's main business now is not this type of drug.

But the key point is that Pfizer's revenue and profits have been plummeting since last year.

The revenue plummeted from $100 billion in the previous year to more than $50 billion last year, so that the revenue in the two quarters of this year was not very ideal.

Last year, the company achieved revenue of $100 billion, mainly thanks to vaccines and drugs for certain diseases, thus setting a record high and becoming the first pharmaceutical giant with sales exceeding $100 billion.

Its net profit reached more than 300 billion US dollars, which is also a record high for Pfizer.

But the problem is that these revenues and profits all come from vaccines and drugs for one disease, which alone contributed more than $567 billion, or more than half.